Active ingredient
Methylphenidate NDC Codes
Methylphenidate is an active ingredient in 20 finished products listed with the FDA, under 6 names.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Brand and generic names
- Methylphenidate Transdermal System, Methylphenidate, Daytrana, Methylphenidate Extended-Release, Cotempla XR-ODT, Methylphenidate Hydrochloride
- Labelers
- PADAGIS US LLC, Mylan Pharmaceuticals Inc., Noven Therapeutics, LLC, Neos Therapeutics, LP, Neos Therapeutics Brands, LLC, Ascent Pharmaceuticals, Inc.
- Strengths
- Methylphenidate 8.6 mg/1; Methylphenidate 17.3 mg/1; Methylphenidate 25.9 mg/1; Methylphenidate 55 mg/mg; Methylphenidate 27.5 mg/mg; Methylphenidate 41.3 mg/mg; Methylphenidate 82.5 mg/mg; Methylphenidate 1.1 mg/h; Methylphenidate 2.2 mg/h; Methylphenidate 3.3 mg/h; Methylphenidate 1.6 mg/h; Methylphenidate 5 mg/5mL; Methylphenidate 10 mg/5mL; Methylphenidate 10 mg/9h; Methylphenidate 15 mg/9h; Methylphenidate 20 mg/9h; Methylphenidate 30 mg/9h
- Dosage forms
- Patch, Tablet, Orally disintegrating, Solution
- Routes
- Transdermal, Oral
- Drug classes (FDA established)
- Central Nervous System Stimulant
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 22
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Methylphenidate Extended-Release | Methylphenidate 8.6 mg/1 | Tablet, Orally disintegratingOral | Neos Therapeutics, LP | 62542-100 | 62542-0100-31 | — |
| Methylphenidate Extended-Release | Methylphenidate 17.3 mg/1 | Tablet, Orally disintegratingOral | Neos Therapeutics, LP | 62542-250 | 62542-0250-31 | — |
| Methylphenidate Extended-Release | Methylphenidate 25.9 mg/1 | Tablet, Orally disintegratingOral | Neos Therapeutics, LP | 62542-350 | 62542-0350-31 | — |
| Methylphenidate Transdermal Systemmethylphenidate | Methylphenidate 55 mg/mg | PatchTransdermal | PADAGIS US LLC | 0574-2420 | 00574-2420-65 | — |
| Methylphenidate Transdermal Systemmethylphenidate | Methylphenidate 27.5 mg/mg | PatchTransdermal | PADAGIS US LLC | 0574-2410 | 00574-2410-65 | — |
| Methylphenidate Transdermal Systemmethylphenidate | Methylphenidate 41.3 mg/mg | PatchTransdermal | PADAGIS US LLC | 0574-2415 | 00574-2415-65 | — |
| Methylphenidate Transdermal Systemmethylphenidate | Methylphenidate 82.5 mg/mg | PatchTransdermal | PADAGIS US LLC | 0574-2430 | 00574-2430-65 | — |
| Methylphenidate | Methylphenidate 1.1 mg/h | PatchTransdermal | Mylan Pharmaceuticals Inc. | 0378-8260 | 00378-8260-93 | — |
| Methylphenidate | Methylphenidate 2.2 mg/h | PatchTransdermal | Mylan Pharmaceuticals Inc. | 0378-8262 | 00378-8262-93 | — |
| Methylphenidate | Methylphenidate 3.3 mg/h | PatchTransdermal | Mylan Pharmaceuticals Inc. | 0378-8263 | 00378-8263-93 | — |
| Methylphenidate | Methylphenidate 1.6 mg/h | PatchTransdermal | Mylan Pharmaceuticals Inc. | 0378-8261 | 00378-8261-93 | — |
| Methylphenidate Hydrochloride | Methylphenidate 5 mg/5mL | SolutionOral | Ascent Pharmaceuticals, Inc. | 43602-177 | 43602-0177-0543602-0177-25 | — |
| Methylphenidate Hydrochloride | Methylphenidate 10 mg/5mL | SolutionOral | Ascent Pharmaceuticals, Inc. | 43602-178 | 43602-0178-0543602-0178-25 | — |
| Cotempla XR-ODTmethylphenidate | Methylphenidate 8.6 mg/1 | Tablet, Orally disintegratingOral | Neos Therapeutics Brands, LLC | 70165-100 | 70165-0100-30 | — |
| Cotempla XR-ODTmethylphenidate | Methylphenidate 17.3 mg/1 | Tablet, Orally disintegratingOral | Neos Therapeutics Brands, LLC | 70165-200 | 70165-0200-30 | — |
| Cotempla XR-ODTmethylphenidate | Methylphenidate 25.9 mg/1 | Tablet, Orally disintegratingOral | Neos Therapeutics Brands, LLC | 70165-300 | 70165-0300-30 | — |
| Daytranamethylphenidate | Methylphenidate 10 mg/9h | PatchTransdermal | Noven Therapeutics, LLC | 68968-5552 | 68968-5552-03 | — |
| Daytranamethylphenidate | Methylphenidate 15 mg/9h | PatchTransdermal | Noven Therapeutics, LLC | 68968-5553 | 68968-5553-03 | — |
| Daytranamethylphenidate | Methylphenidate 20 mg/9h | PatchTransdermal | Noven Therapeutics, LLC | 68968-5554 | 68968-5554-03 | — |
| Daytranamethylphenidate | Methylphenidate 30 mg/9h | PatchTransdermal | Noven Therapeutics, LLC | 68968-5555 | 68968-5555-03 | — |
Methylphenidate: common questions
- Which drugs contain Methylphenidate?
- Methylphenidate Transdermal System, Methylphenidate, Daytrana, Methylphenidate Extended-Release, Cotempla XR-ODT, Methylphenidate Hydrochloride.
- Is there a J-code for Methylphenidate?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.